These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 2632409)

  • 21. Functional localization of specific receptors mediating gastrointestinal motor correlates of vomiting.
    Lang IM; Marvig J
    Am J Physiol; 1989 Jan; 256(1 Pt 1):G92-9. PubMed ID: 2563202
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of apomorphine on morphine analgesia during the state of dopaminergic supersensitivity after chronic treatment with haloperidol.
    Kamata K; Ogawa K; Noma S; Kameyama T
    J Pharmacobiodyn; 1986 Jan; 9(1):88-94. PubMed ID: 3712211
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Different mechanisms for dopaminergic excitation induced by opiates and cannabinoids in the rat midbrain.
    Melis M; Gessa GL; Diana M
    Prog Neuropsychopharmacol Biol Psychiatry; 2000 Aug; 24(6):993-1006. PubMed ID: 11041539
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition by morphine of the cardiovascular and behavioral responses evoked by centrally administered substance P in conscious rats.
    Itoi K; Jost N; Tschöpe C; Culman J; Badoer E; Unger T
    Neuropharmacology; 1994 Feb; 33(2):181-7. PubMed ID: 7518572
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dopaminergic mechanisms of opiate actions in brain.
    Eidelberg E; Erspamer R
    J Pharmacol Exp Ther; 1975 Jan; 192(1):50-7. PubMed ID: 164529
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Involvement of opioid and dopaminergic systems in isolation-induced pinning and social grooming of young rats.
    Niesink RJ; Van Ree JM
    Neuropharmacology; 1989 Apr; 28(4):411-8. PubMed ID: 2546087
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novelty-induced place preference behavior in rats: effects of opiate and dopaminergic drugs.
    Bardo MT; Neisewander JL; Pierce RC
    Pharmacol Biochem Behav; 1989 Mar; 32(3):683-9. PubMed ID: 2544904
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Blockade of D-2 dopamine receptors strongly enhances the potency of enkephalins to inhibit dopamine-sensitive adenylate cyclase in rat neostriatum: involvement of delta- and mu-opioid receptors.
    Schoffelmeer AN; Hansen HA; Stoof JC; Mulder AH
    J Neurosci; 1986 Aug; 6(8):2235-9. PubMed ID: 3018189
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Potentiation by naloxone of pressor reflexes.
    Montastruc JL; Montastruc P; Morales-Olivas F
    Br J Pharmacol; 1981 Sep; 74(1):105-9. PubMed ID: 7272594
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Naloxone-induced jumping activity in morphine-dependent mice: a pharmacological study on the role of DA2 receptors.
    Cerbo R; Boni B; De Lena C; Cesarino F; Meco G; Feliciani M; Formisano R; Casacchia M
    Boll Soc Ital Biol Sper; 1984 Mar; 60(3):493-9. PubMed ID: 6712813
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Morphine-induced straub tail response: mediated by central mu2-opioid receptor.
    Nath C; Gupta MB; Patnaik GK; Dhawan KN
    Eur J Pharmacol; 1994 Sep; 263(1-2):203-5. PubMed ID: 7821354
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of haloperidol on morphine-induced antinociception morphine tolerance and withdrawal in hyperprolactinaemic rats.
    Drago F; Kovács GL; Szabo G; Scapagnini U; Telegdy G
    Neuropharmacology; 1985 Nov; 24(11):1027-31. PubMed ID: 4080101
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Spinal site of antiarrhythmic action of morphine and pethidine in normal and spinal cord transected dogs.
    Pant KK; Gurtu S; Sinha JN; Tangri KK; Bhargava KP
    J Auton Pharmacol; 1984 Mar; 4(1):11-5. PubMed ID: 6715392
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Involvement of mu-opioid receptors in potentiation of apomorphine-induced climbing behavior by morphine: studies using mu-opioid receptor gene knockout mice.
    Jang C; Park Y; Tanaka S; Ma T; Loh HH; Ho IK
    Brain Res Mol Brain Res; 2000 May; 78(1-2):204-6. PubMed ID: 10891603
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Naloxone pretreatment blocks acute morphine-induced sensitization to naltrexone.
    White-Gbadebo D; Holtzman S
    Psychopharmacology (Berl); 1994 Mar; 114(2):225-8. PubMed ID: 7838911
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of dopaminergic modifiers on morphine-induced analgesia and respiratory depression.
    McGilliard KL; Takemori AE
    Eur J Pharmacol; 1979 Feb; 54(1-2):61-8. PubMed ID: 33817
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Decrease in serum prolactin by naloxone: evidence against antidopamine and antipsychotic effects.
    Gold MS; Pottash AL; Extein I; Redmond DE; Kleber HD
    Am J Psychiatry; 1979 Oct; 136(10):1339-40. PubMed ID: 114063
    [No Abstract]   [Full Text] [Related]  

  • 38. Inhibitory effect of opiates on male rat sexual behavior may be mediated by opiate receptors outside the central nervous system.
    Agmo A; Rojas J; Vázquez P
    Psychopharmacology (Berl); 1992; 107(1):89-96. PubMed ID: 1317041
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Naloxone inhibits the centrally-mediated hypotensive actions of BHT-933 (azepexole).
    Tackett RL; Laskey R
    Life Sci; 1987 Oct; 41(17):2063-7. PubMed ID: 2823037
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Opiate and dopamine receptors in the isolated nictitating membrane of the cat.
    Illés P; Knoll J
    Pol J Pharmacol Pharm; 1978; 30(2-3):293-304. PubMed ID: 209424
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.